Monitor for any conversion to a Schedule 13D if Boston Partners engages in activist activities, but the passive certification makes this unlikely in the near term.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $5.84entry
- T+1 · 19h ago −3.60%α −1.68% · $5.63
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Boston Partners filed an amended Schedule 13G disclosing a 6.16% passive stake in Cytek Biosciences as of September 30, 2026, up from a prior 5.6% stake. The increase is modest and routine for a passive institutional investor.
Key Financial Metrics
Key Facts
- Boston Partners reported beneficial ownership of 8,002,638 shares of Cytek Biosciences common stock as of September 30, 2026.
- The stake represents 6.16% of shares outstanding, up from 5.6% in the prior filing.
- Boston Partners is a registered investment adviser filing under Rule 13d-1(b) as a passive investor.
- The filing certifies the securities were acquired and are held in the ordinary course of business, not to influence control.
Financial Impact
Stake increased by approximately 0.56 percentage points; no dollar value disclosed.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001386060-26-000063 |
| Document: 0001386060-26-000063-index.html | 0001386060-26-000063 |
| Document: 0001386060-26-000063.txt | 0001386060-26-000063 |
Track record
14 reports on CTKB
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +1.49% at T+1 after the Jun 11, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago ITC Section 337 Neutral 3/10 Entry $5.78 Now $5.63 −2.60% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $5.84 to $5.63 Now $5.63 −3.60% ▼ −3.60% −1.68% vs SPY
- Nov 10, 20266d ago Institutional Cluster Bullish 4/10 Entry $5.79 to $5.76 Now $5.63 −2.76% ▼ −0.52% −1.84% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $5.40 to $5.83 Now $5.63 +4.26% ▲ +7.96% +7.65% vs SPY
- Nov 3, 202613d ago SC 13G/A Neutral 2/10 Entry $5.88 to $5.40 Now $5.63 −4.25% ▼ −8.16% −3.75% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $5.43 to $5.59 Now $5.63 +3.68% ▲ +2.95% +3.47% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $5.71 to $5.68 Now $5.63 −1.40% ▼ −0.53% +0.19% vs SPY
- Aug 24, 202612w ago 8-K Bearish 7/10 Entry $4.44 to $4.58 Now $5.63 −26.80% ▼ −3.15% −2.83% vs SPY
- Jun 25, 202620w ago 8-K Neutral 2/10 Entry $4.48 to $4.34 Now $5.63 +25.67% ▼ −3.13% −4.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers